GVIndicator VenturesCasdin CapitalLogos CapitalGeneral CatalystCatalio Capital ManagementS32InnovivaSamsung NextKicker VenturesPalo Santo VCJSL Health
Description
Beacon Biosignals, a Boston, MA-based company leveraging brain data to advance human health, raised an $11M extension to its Series B financing. The upsized round brings the cumulative funding to over $132M. The company intends to use the funds to accelerate its mission to transform brain health with innovative EEG technology. Led by CEO Jacob Donoghue, Beacon combines wearable tech with advanced AI to enhance brain function diagnostics.
Who to call at Beacon Biosignals, and when
A new round usually means Beacon Biosignals is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Beacon Biosignals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Beacon Biosignals, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Beacon Biosignals
Location
80 REVERE ST., #10
Boston, Massachusetts, United States
About
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Biosignals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonInformation TechnologySoftware